Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Assets Average (2024 - 2025)

CG Oncology (CGON) has disclosed Assets Average for 2 consecutive years, with $760.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Assets Average rose 16.39% year-over-year to $760.8 million, compared with a TTM value of $760.8 million through Dec 2025, up 16.39%, and an annual FY2025 reading of $773.2 million, up 62.08% over the prior year.
  • Assets Average was $760.8 million for Q4 2025 at CG Oncology, up from $715.7 million in the prior quarter.
  • Across five years, Assets Average topped out at $760.8 million in Q4 2025 and bottomed at $389.2 million in Q1 2024.